baber/WOPTO huggingface dataset:
Patent JP-H0731603-B2 (JP)
IPC: G06F9/44
Filed: 1985-11-21
Abstract: A language specific microprocessor for the computer language known as FORTH is disclosed. The microprocessor includes four main registers each for holding a parameter; a L or instruction latch register for decoding instructions and activating microprocessor operation; an I or return index register for tracking returns; an N or next parameter register for operation with an arithmetic logic unit (ALU); and a T or top of parameter stack register with an appended ALU. A return stack port is connected to the I register and a parameter stack port is connected to the N register circuit, each have last in first out (LIFO) memory stacks for reads writes to isolated independent memory islands that are external to the microprocessor. The respective I, T and N registers are connected in respective series by paired bus connections for swapping parameters between adjacent registers. A first split 16 bit multiplexer J/K controls the LIFO stack for the I and N registers on paired 8 bit address stacks; a second 16 bit multiplexer designates the pointer to main memory with 65K addresses and an adjoining 65K for data. This addressing multiplexer receives selective input from a program counter P, the return index register I, the top of the parameter stack T and/or the instruction latch L. Movement to subroutine is handled in a single cycle with returns being handled at the end of any designated cycle. Asynchronous microprocessor operation is provided with the address multiplexer being simultaneously set up with an address to a future machine step, unloading from memory of appropriate data or instruction for the next machine step and asynchronously executing the current machine step. A two-phase clock latches data as valid on a rising edge and moves to a new memory location on a falling edge. This two phase clock is given a pulse width sufficient for all asynchronous cycles of mocroprocessor operations to settle. The microprocessor's assembler language is FORTH and the stack and main memory port architecture uniquely complements FORTH to produce a small (17,000 gates) fast (40 mips) microprocessor operable on extant FORTH programs. Provision is made for an additional G port which enables the current operating state of the microprocessor to be mapped, addressing of up to 21 bits as well as the ability to operate the microprocessor in tandem with similar microprocessors.
Patent JP-2623261-B2 (JP)
Inventor: WILLIAMS JEFFREY L
IPC: G06F15/177
Filed: 1987-11-05
Granted: 1997-06-25
Abstract: A computer system of the type having a processor section (12), a memory section (14), an input-output section (16), a system clock (44), and a system bus (18) for communicating signals between the sections, accommodates a variable number of processor units in the processor section. The processor section hence is expandable. Synchronization is distributed in that each processor unit can synchronize all the units in the processor section. The processor units arbitrate for access to the system bus, and respond to interrupts, on a distributed basis. A distribution counter in each processor unit provides a periodically sequencing unique count to distribute tasks among the processor units.
Patent JP-2930618-B2 (JP)
IPC: G01N15/14
Filed: 1989-10-27
Granted: 1999-08-03
Abstract: With this interactive method, a plurality of various adjoining image fields of a cell culture are picked up several times in parallel in a time sequence and stored as digital images. 
<??>Subsequently, the digital images, following one another in time, of one image field are successively displayed on the screen and the cells in the image field are marked, different markers being provided for different types of cells and cell generations. 
<??>From the stored number and the positions of the markers, statistical characteristics are subsequently determined which are characteristic of the cells in the image fields or of the cell culture. 
<IMAGE>
Patent JP-3371097-B2 (JP)
IPC: B01F3/04
Filed: 1999-10-05
Granted: 2003-01-27
Abstract: A combined liquid/vapour distributor unit (20) for distributing a liquid and a vapour to or from a packing in an exchange column comprises a distributor (22) having at least one vapour riser (36) and at least one liquid trough (28) adjacent the vapour riser (36). The vapour riser (36) has generally parallel spaced apart upright walls and an open top and an open bottom opposite the open top and the liquid trough (28) has an open top and a floor having at least one aperture. The floor is opposite the open top of the liquid trough (28) and is attached to at least one wall of the adjacent vapour riser (36). A perforated cap covers the open end of the vapour riser (36) or a deck (24), having at least one aperture (40) vertically aligned with the open top of the vapour riser (36) and at least one aperture (42) vertically aligned with the open top of the liquid trough (28), is located above the distributor (22). The distributor (22) can have disposed therein one or more nozzles for liquid or vapour draw or feed or two phase feed. <IMAGE>
Patent JP-2615325-B2 (JP)
IPC: C12N9/96
Filed: 1992-10-27
Granted: 1997-05-28
Abstract: A storage-stable POD conjugate solution is characterised by a pH of 5.0 to 6.5 which is adjusted by an organic buffer substance in a concentration of 40 to 100 mmol/l and/or 0.05 to 1.0 mol/l magnesium aspartate.
Patent JP-2937903-B2 (JP)
IPC: A61K31/7088
Filed: 1996-11-13
Granted: 1999-08-23
Abstract: Compositions and methods are provided for the treatment and diagnosis of diseases amenable to treatment through modulation of the synthesis or metabolism of intercellular adhesion molecules. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial leukocyte adhesion molecule-1. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, and intervening sequences. Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating cell adhesion proteins with an oligonucleotide specifically hybridizable with RNA or DNA corresponding to one of the foregoing proteins are disclosed. Methods for treatment of diseases responding to modulation cell adhesion molecules are disclosed.
Patent JP-H0575367-B2 (JP)
Inventor: DERETSUKU ROBIN HEISUMAN
IPC: A23L23/10
Filed: 1986-12-19
Abstract: A particulate creamer-thickener comprises 5-45%, preferably 10-25% by weight of fat (preferably having a melting point of 30-45°C, 0.05-5%, preferably 0.1-3% by weight of a proteinaceous emulsifier (e.g. sodium caseinate) or a fatty acid emulsifier, 25-75% by weight of starch thickener and from 0-8% by weight of water. Also a process of its manufacture has been described.
Patent JP-3746174-B2 (JP)
IPC: A61P5/44
Filed: 1999-11-05
Granted: 2006-02-15
Abstract: Mometasone 17- furoate is made by direct esterification of the 17- hydroxyl group of mometasone using 2-furoyl chloride in the presence of a tertiary amine and an inert solvent, without prior protection of the free 11-hydroxy function.
Patent JP-2713409-B2 (JP)
IPC: H01L29/72
Filed: 1987-12-22
Granted: 1998-02-16
Abstract: A complementary Silicon-On-Insulator (SOI) Lateral Insulated Gate Rectifier (LIGR) is fabricated in a monocrystalline silicon layer provided on a major surface of a substantially insulating substrate. The monocrystalline silicon layer includes a number of adjacent, doped coplanar layer portions, with the complementary SOI LIGR device being formed of adjacent, contacting layer portions forming two complementary LIGR elements with a common source region. The common source region, as well as both of the drain regions of the device, are composed of regions of both the first and second conductivity types. In this manner, a simple, easily fabricated, balanced, high performance complementary LIGR structure is obtained in which undesired substrate currents are substantially eliminated.
Patent JP-2950481-B2 (JP)
IPC: C23C22/68
Filed: 1990-11-29
Granted: 1999-09-20
Abstract: A method for the corrosion-prevention treatment of a metal suface comprises projecting onto a metal surface a shot-blast particulate material consisting of a core of iron or an iron alloy, an undercoat of a iron-zinc alloy and a top coat of zinc or a zinc alloy, thereby forming a coating film of zinc or the zinc alloy on the metal surface, and bringing the thus coated metal surface into contact with an aqueous suspension of silica and an aqueous solution containing ions of at least one metal selected among Ti, Zr, Mg, Ba, Sr, W, Ni, Co, Sn, Mo, and Mn.
Patent JP-3304146-B2 (JP)
IPC: H01L27/108
Filed: 1992-11-27
Granted: 2002-07-22
Abstract: The arrangement relates to bit lines which are widened to form contact surfaces (11, 21, 31, 41, 51) at the contacts (10, 20, 30, 40, 50) to underlying cells, the contacts being arranged in an at least a three-fold stagger. A minimum space requirement is achieved in conjunction with increased reliability when the distance bSp between edges of adjacent bit lines has the same value everywhere, and the contact surfaces can thereby be enlarged.
Patent JP-3258407-B2 (JP)
IPC: C12N15/02
Filed: 1992-12-17
Granted: 2002-02-18
Abstract: Monitoring the progression of breast cancer by performing a series of specific immunoassays over time to determine changes in the level of tumor marker NCA-BT in blood, e.g., serum, samples obtained from the patient. Increases in blood NCA-BT levels are indicative of a deteriorating condition whereas decreasing levels of blood NCA-BT indicate an improving condition. <IMAGE>
Patent JP-3238418-B2 (JP)
IPC: C07K16/00
Filed: 1990-12-22
Granted: 2001-12-17
Abstract: The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.
Patent JP-2927539-B2 (JP)
IPC: A61P31/00
Filed: 1989-12-05
Granted: 1999-07-28
Abstract: A compound comprising a deletion analogue of an amide or carboxy-terminating Magainin I of the following structural formula using the single letter amino acid code:  <IMAGE>  and wherein at least one of amino acid residues 15 through 23 is omitted; or a deletion analogue of an amide or carboxy-terminated Magainin II of the following structural formula using the single letter amino acid code:  <IMAGE>  and wherein at least one of amino acid residues 15 through 23 is omitted. These compounds can be effectively used as pharmaceutical compositions.
Patent JP-2974762-B2 (JP)
IPC: B65G49/04
Filed: 1990-02-21
Granted: 1999-11-10
Abstract: PCT No. PCT/EP90/00295 Sec. 371 Date Nov. 6, 1991 Sec. 102(e) Date Nov. 6, 1991 PCT Filed Feb. 21, 1990 PCT Pub. No. WO90/10739 PCT Pub. Date Sep. 20, 1990.The conveying trough of the vibrator conveyor is disposed spirally around a central pipe and is surrounded by a gasproof vessel. This vessel contains a treatment medium, preferably an electrolyte free of oxygen and water, into which the vibrator conveyor with thee central pipe dips partially. According to the invention, a gas cushion (10) is provided between the bottom (3) or the cover (4) of the central pipe (2) and the bottom (8) of the vessel (6). In this form of realization bulk material can be transported over great differences in height.
Patent JP-3759162-B2 (JP)
IPC: A61K35/10
Filed: 1992-03-04
Granted: 2006-03-22
Abstract: The peat-derived bioactive product contains not more than 70%, preferably not more than 60% by weight of inorganic salts, especially of sodium chloride, based on dry solids. It is obtainable by a process wherein a highly concentrated aqueous solution of inorganic salts, especially of sodium chloride containing peat-derived bioactive ingredients is diluted with demineralized water and subjected to reverse osmosis in order to desalinate the solution, inorganic salts being removed, and wherein the resulting solution is concentrated and clarified, and, optionally, in at least one further step, sterilized and/or spray-dried. A pharmaceutical formulation containing a peat-derived bioactive product, in the form of a gel, is prepared by combining a sterile alcoholic herb extract with sterile glycerol, a sterile aqueous solution of previously powdered peat-derived bioactive product and a sterile menthol solution; the resulting mixture is gradually combined with colloidal silica to convert the liquid composition into gel form, the weight ratio of liquid mixture to silica preferably being from 90:10 to 94:6. A cosmetic preparation such as a gel, ointment, balm, shampoo, bath salt lotion etc. contains as active ingredient the instant peat-derived bioactive product in a quantity of 0.01-10% by weight, preferably 0.05-1% by weight, more preferably 0.05-0.1% by weight.
Patent JP-2681061-B2 (JP)
IPC: G01N33/532
Filed: 1989-06-05
Granted: 1997-11-19
Abstract: Specific binding assays are disclosed which utilize a sensitizer as a label. Such sensitizers include any moiety which, when stimulated by "excitation" with radiation of one or more wavelengths or other chemical or physical stimulus (e.g., electron transfer, electrolysis, electroluminescence or energy transfer), will achieve an excited state which (a) upon interaction with molecular oxygen will produce singlet molecular oxygen, or (b) upon interaction with a leucodye will assume a reduced form which can then be returned to its original unexcited state by interaction with molecular oxygen resulting in the production of hydrogen peroxide. Either interaction with the excited sensitizer will, with the addition of other reagents, produce a detectable signal.
Patent JP-3657267-B2 (JP)
IPC: H02K3/22
Filed: 1995-07-31
Granted: 2005-06-08
Abstract: A conductor bar configuration includes a multiplicity of conductor bars extending along a longitudinal axis, stacked on one another along a vertical axis and each having four cooling ducts aligned parallel to the longitudinal axis, disposed next to one another in pairs in the direction of a transverse axis perpendicular to the longitudinal axis and to the vertical axis and disposed one behind another in pairs along the longitudinal axis. Each cooling duct has an associated orifice in the vicinity of one end of the configuration and reaches into one of two gas outlet zones disposed approximately in the middle relative to the longitudinal axis, where it merges into an outlet duct directed at an acute angle to the vertical axis. For each pair of cooling ducts situated next to one another in the case of each conductor bar, the orifice of one cooling duct is disposed directly at one end and the orifice of the other cooling duct is spaced from that end. For each pair of cooling ducts disposed one behind another the orifice of one cooling duct is disposed directly at that end to which it leads, and the orifice of the other cooling duct is spaced from that end to which it leads. A rotor assembly includes a multiplicity of identical configurations and is suitable for forming a rotor winding of an electric machine, in particular a turbogenerator. The conductor bars are interconnected by conductor bows disposed at each end and bent approximately in the shape of a circular arc about the longitudinal axis.
Patent JP-2532936-B2 (JP)
IPC: B23B27/22
Filed: 1988-07-26
Granted: 1996-09-11
Abstract: An improved cutting insert with chip control features and a method for manufacturing the same. An insert body having wall regions, sides and top and bottom walls is adapted for mounting in a pocket in a holder. The insert body has cutting edges and a diagonal notch in the top and bottom sides. A land region extends rearwardly from the end wall region toward the respective top or bottom wall and defines a surface region of a predetermined width. A descending wall initiates in a portion of the land and terminates in a planar floor region having a forward, a rearward and opposed side edges. A back ramp extends upwardly from the planar floor rearward edge and terminates at the respective top or bottom wall. The end wall region can include at least one flat land region adjacent the land region. The flat land region defines a selectively removable portion of the end wall region and after any selective removal thereof represents no more than approximately one-third of the total width of the end wall region. <IMAGE>
Patent JP-3093260-B2 (JP)
IPC: A61B19/00
Filed: 1991-05-07
Granted: 2000-10-03
Abstract: A clinical appliance (10) which is useful for taking samples from a tissue or a tissue associated material is disclosed. The appliance (10) has a head (13), and a handle (11) and a pressure sensitive element which comprises the head (13) and the handle (11) attached by a resiliently deformable member (12), and an instrument (140 retained in the head. Marks (21) are provided respectively on the head (13) and the handle (11) to indicate that when the marks are aligned a selected force is being exerted on the instrument (14). A portion of the instrument (14) consists of a needle member for probing periodontal pockets.
Patent JP-H0667621-B2 (JP)
IPC: B41J2/07
Filed: 1989-09-22
Abstract: PCT No. PCT/FR89/00484 Sec. 371 Date May 17, 1990 Sec. 102(e) Date May 17, 1990 PCT Filed Sep. 11, 1989 PCT Pub. No. WO90/03271 PCT Pub. Date Apr. 5, 1990.A device for controlling and regulating a continuous ink jet printer wherein a jet (J) is fractionated into droplets charged in a charge electrode (6) and which then pass between deflection electrodes, a sensor (8) is provided which includes a conductor element (8c) having two parts which are symmetrical with respect to the trajectory of the droplets. The device includes a circuit (9) which determines and processes the first I(t) and second J(t) derivatives with respect to the time of the charge induced in the conductor element (8c) by charged droplets (Gc) in order to determine their speed. The device includes means for regulating the speed of droplets and means for regulating the ink quality.
Patent JP-3111075-B2 (JP)
IPC: C07K14/815
Filed: 1991-06-28
Granted: 2000-11-20
Abstract: This invention relates to peptide derivatives which are useful anticoagulant agents.
Patent JP-3058688-B2 (JP)
IPC: A61K31/40
Filed: 1991-06-17
Granted: 2000-07-04
Abstract: The present invention is directed a new group of indole derivatives that are NMDA antagonists.
Patent JP-2854971-B2 (JP)
IPC: C07C225/36
Filed: 1990-10-12
Granted: 1999-02-10
Abstract: PCT No. PCT/GB90/01574 Sec. 371 Date Apr. 10, 1991 Sec. 102(e) Date Apr. 10, 1991 PCT Filed Oct. 12, 1990.Compounds of formula (I) <IMAGE> (I)  in which R1, R2, R3 and R4 are each separately selected from hydrogen, X, NH-A-NHR and NH-A-N(O)R'R'' wherein X is hydroxy, halogeno, amino, C1-4 alkoxy or C2-8 alkanoyloxy, A is a C2-4 alkylene group with a chain length between NH and NHR or N(O)R'R'' of at least 2 carbon atoms and R, R' and R'' are each separately selected from C1-4 alkyl groups and C2-4 hydroxyalkyl and C2-4 dihydroxyalkyl groups in which the carbon atom attached to the nitrogen atom does not carry a hydroxy group and no carbon atom is substituted by two hydroxy groups, or R' and R'' together are a C2-6 alkylene group which with the nitrogen atom to which R'' and R'' are attached forms a heterocyclic group having 3 to 7 atoms in the ring, but with the proviso that at least one of R1 to R4 is a group NH-A-N(O)R'R'', and physiologically acceptable salts thereof are of value in the treatment of cancer.
Patent JP-3863566-B2 (JP)
IPC: G01N33/18
Filed: 1996-09-18
Granted: 2006-12-27
Abstract: PCT No. PCT/EP96/04083 Sec. 371 Date Jul. 9, 1998 Sec. 102(e) Date Jul. 9, 1998 PCT Filed Sep. 18, 1996 PCT Pub. No. WO97/14960 PCT Pub. Date Apr. 24, 1997In order to determine the biological oxygen demand of sewage, a sample of sewage is taken into a reaction vessel in which there is a biological bath which is kept moving turbulently by an agitator. An oxygen probe measure the oxygen consumption per unit time. After each measuring cycle the reaction vessel is rinsed with diluting water and is then ready for another measuring cycle. The reaction vessel penetrates into the sewage to be tested. The sewage sample enters the reaction vessel via an aperture.
Patent JP-3581154-B2 (JP)
IPC: E06B3/677
Filed: 1995-06-02
Granted: 2004-10-27
Abstract: The present invention provides a method and apparatus for assembling a small number of custom sealed double glazing units in which spacers can have different widths and panes of different assemblies can be differently sized. In accordance with one method of the invention, a spacer having sealant on opposing surfaces thereof is adhered to a first glass pane and a resilient member is positioned alongside a portion of the spacer. A second glass pane is positioned over the spacer so that it is partially adhered to the spacer to define an interpane space around which the spacer is adhered, but with the resilient member preventing contact with the whole of the spacer, so maintaining a gap between a portion of the spacer and the second glass pane. The resulting assembly is moved into a gas exchange chamber, and air is removed from the chamber and accordingly also the interpane space. A gas having a coefficient of thermal conductivity lower than that of air is introduced into the chamber and accordingly also the interpane space, and the glass panes are pressed together while in the gas exchange chamber to compress the resilient member and adhere the second glass pane to all of the spacer to seal the interpane space.
Patent JP-4393582-B2 (JP)
IPC: C11D3/395
Filed: 1995-04-03
Granted: 2010-01-06
Abstract: There is a provided a detergent composition containing: (a) a heavy metal ion sequestrant; and (b) an organic peroxyacid bleaching system wherein a means is provided for delaying the release to a wash solution of said peroxyacid bleach relative to the release of said heavy metal ion sequestrant. Preferably said composition additionally contains (c) a water soluble builder wherein a means is provided for delaying the release to a wash solution of said peroxyacid bleach relative to the release of said water soluble builder. A pretreat wash method is also provided.
Patent JP-3874792-B2 (JP)
IPC: C07C17/087
Filed: 1995-05-25
Granted: 2007-01-31
Abstract: A process for the preparation of one or more of CHClFCF3 (HCFC-124), CHF2CClF2 (HCFC-124a) and CHF2CF3 (HFC-125) by reaction of perchloroethylene with hydrogen fluoride in a single stage reaction vessel in the presence of a fluorination catalyst. These compounds are useful in a variety of industrial applications including blowing agents, refrigerants, sterilant gases and solvent applications. Distilling the reaction product produces a distillate comprising HCl, CHClFCF3, CHF2CClF2 and CHF2CF3 and a minor amount of HF which distillate is scrubbed to remove the acids. The bottoms product comprises perchloroethylene, hydrogen fluoride and organic by-products which is phase separated to sequester the hydrogen fluoride from the mixture of perchloroethylene and organic by-products. The hydrogen fluoride and mixture of perchloroethylene with organic by-products are then preferably re-mixed at a controlled rate and recycled to the reaction vessel.